Abstract
Accurate diagnosis of spine lesions is important for its successful management. Imaging–guided percutaneous biopsy is gaining increasing acceptance as a means for obtaining tissue for diagnosis. Most biopsies can be rapidly performed under local anaesthesia, with little patient discomfort and improved safety. Spinal anatomy is, however, complex with many adjacent vital structures. Good knowledge of anatomy and precise needling technique is, therefore, important. Today, biopsy of spinal lesions is best performed under computed tomography (CT) fluoroscopic guidance. Indications for imaging-guided biopsy include confirming metastasis in a patient with a known primary tumour, determining the nature of a solitary bone lesion, excluding malignancy in vertebral body compression, and investigating for infection. Among the various issues to be considered are site of lesion, location of adjacent vital structures, approach, and type and size of needle. Complications are rare, particularly when a meticulous technique is applied. In summary, CT-guided percutaneous biopsy is a safe and an effective technique for the evaluation of spinal lesions and useful in planning therapy.
Keywords: Biopsy, computed tomography, intervention, percutaneous biopsy, spine, vertebral lesions
INTRODUCTION
Biopsy entails the removal of tissue from a living body with the aim of establishing a precise diagnosis, usually by microscopic examination or culture. It can be performed during surgery (open biopsy) or percutaneously (closed biopsy). Percutaneous biopsy of bony lesions may be performed under the guidance of a variety of imaging modalities, such as, fluoroscopy [1-4], computed tomography (CT) [5-19], ultrasonography [20-24], and magnetic resonance (MR) imaging [25-28]. Open biopsy is a major surgical procedure that is associated with morbidity and a host of complications. There are several advantages of imaging-guided biopsy, including avoidance of overnight hospital stay, cost and time saving, earlier commencement of radiation therapy, biopsy of surgically-inaccessible sites, and lower morbidity. The last mentioned advantage includes avoidance of general anaesthetic-related complications, less risk of postoperative wound infection, and decreased likelihood of development of pathological fracture [29-31].
Imaging- guided biopsy of bony lesions is a safe procedure, with development of major complications being rare. Reported accuracy ranges from 68% to 97% [1-4,7,8,10,12,14,16,17,19,21,28,29,32-38]. Fluoroscopy is most often used to guide biopsy of lesions in long bones. Ultrasonography can be used for lesions on or near the surface of bone and, particularly, if there is an associated soft tissue mass or an adjacent cortical destruction [20-24]. MR imaging has been advocated for biopsy of musculoskeletal lesions, particularly for those that are not clearly visible on fluoroscopy or CT [25-28]. The choice of imaging guidance modality to be employed is determined by individual operator preference and the availability of equipment and facilities, e.g., open MR magnet and MR-compatible accessories.
Although the use of fluoroscopy [3,4], ultrasonography [21], and MR imaging [28] has been described, CT is currently the modality of choice for guiding biopsy of lesions of the spine [5,6,8,10-12,14-19]. Ultrasonography has been advocated for guiding biopsy of cervical spine lesions, and in the thoracic and lumbosacral regions its use is limited to lesions affecting the posterior elements [21]. Compared with fluoroscopy, CT more precisely shows the needle position and is potentially safer as there is less likelihood of injury to adjacent structures, such as, major vessels and nerve roots. With CT fluoroscopy, near real-time imaging is possible (Figure 1). The radiation dosage in CT fluoroscopy is also relatively small, compared with conventional diagnostic CT [39]. This review highlights the utility of CT fluoroscopy to guide percutaneous biopsy of spinal lesions.
GENERAL PRINCIPLES AND PREPARATION
A well-planned and executed biopsy is essential for accurate diagnosis and enables appropriate treatment. For a suspected primary tumour, biopsy should be performed at centres that specialise in the treatment of bone tumours. At these centres, joint management decisions are taken by a multidisciplinary team that includes surgeons, oncologists, pathologists, and radiologists. All imaging, particularly MR imaging, should be completed prior to biopsy. The radiologist should review the clinical data and all imaging studies to ensure that a biopsy is indicated and to determine the most appropriate biopsy site. Radiographs provide an overview of the lesion and its characteristics, and they are probably the best single modality for providing a diagnosis or short list of differential diagnoses. In complex-shaped bones, such as, the spine, CT aids in showing lesion details and the presence of associated calcification. Bone scintigraphy helps determine the extent and distribution of the disease. MR imaging is best for defining the local extent of the disease, particularly for radiographically-occult or subtle lesions, marrow involvement, and associated soft tissue components [40].
The biopsy route should be planned such that it does not compromise the neurovascular bundles, and uninvolved tissue compartments should not be crossed. The biopsy should be done in consultation with the surgeon who will be performing the definitive surgery and ideally also with the pathologist who will be examining the specimen. The radiologist should aim to obtain at least three specimens during biopsy, particularly if a cytotechnologist is not present during the procedure to confirm adequacy of the biopsy specimen. Anticoagulants should be discontinued prior to biopsy, and for assessment of infection antibiotics should be stopped at least 48 hours before the biopsy. Other factors to be considered prior to biopsy are blood tests for coagulopathy (prothrombin time, activated partial thromboplastin time, international normalised ratio), platelet counts, need for sedation or anti-anxiety premedication, and written informed consent [40].
INDICATIONS
Indications for biopsy of spinal lesions include [14,40-43]:
Confirm or exclude metastasis in a patient with a known primary tumour.
Determine the nature of a solitary bone lesion with non-specific imaging findings.
Exclude malignancy in vertebral body compression, especially metastases or myeloma (Figure 2).
Evaluation for tumour recurrence.
Investigation for infection to confirm diagnosis and to obtain sample of organism, e.g., discitis or osteomyelitis (Figure 3).
CONTRAINDICATIONS
Contraindications include [40-43]:
Bleeding diathesis.
Decreased platelet count (<50,000/mm3).
Suspected vascular lesion in the thoracic vertebra. Haemorrhage leading to cord compression may occur.
Infected soft tissues surrounding bony lesion to be biopsied, particularly when a non-infective lesion is suspected.
Inaccessible sites, e.g., C1 and odontoid lesions.
Uncooperative patient. General anaesthesia may be required.
TECHNIQUE AND EQUIPMENT
During CT fluoroscopy the patient is positioned to facilitate needle access to the lesion and, ideally, also to ensure as much comfort as possible. For biopsy of thoracic and lumbosacral spine lesions, the patient usually lies in a prone position. For the cervical spine, patients may be placed prone for lesions located in the pedicles and posterior elements. For anteriorly-located cervical spine lesions, the patient lies in a supine position. Sometimes, the patient may have to be placed in a lateral decubitus, semi-prone or semi-supine position, to ensure patient comfort and to minimise patient movement. Although the radiation dosage in CT fluoroscopy is relatively small, compared with conventional diagnostic CT [39], care should still be taken to minimise irradiation to both the patient and the operator. Adopting very short bursts of intermittent CT fluoroscopic screening, using “last image hold” to study the needle position on the monitor, and saving a few representative CT fluoroscopic images from the monitor for reporting purposes will help reduce radiation dosage to the patient. It is possible for the operator to avoid radiation exposure altogether. The operator stands behind a lead glass shield in the CT suite and moves the CT couch-top via remote control. My own preference is to move the couch-top manually, screen intermittently only while standing behind the lead glass shield, and make several fine adjustments to the needle position after studying the images on the monitor, until the needle tip is in the correct position (Figure 1).
The patient’s vital signs should be continuously monitored during the procedure. Following preliminary axial CT scanning, the most appropriate slice is selected to plan the most ideal route for directing the needle into the lesion (Figure 4). Generally, if there are multiple lesions, the largest and most superficial lesion is chosen. Any soft tissue mass related to the bony lesion should also be biopsied. For suspected discitis, in addition to the disc, the adjacent subchondral bone should also be biopsied as this is the site of origin of haematogeneous spondylodiscitis [19] (Figure 3). In planning the needle route, vital anatomical structures, e.g., major blood vessels, nerves, peritoneal cavity, and spinal canal and its contents, should be avoided. In the cervical spine, important structures to avoid include the trachea, oesophagus, internal jugular vein, and carotid artery. In the thoracic spine, care must be taken to avoid the pleural cavity, thoracic aorta, and superior vena cava. In the lumbar spine, the abdominal aorta, inferior vena cava, renal vessels, nerve roots, and organs, such as, the kidneys should not be punctured.
The lesion depth, entry point, and angle of the chosen needle route should be estimated or measured on the most appropriate CT image. The point of entry at the patient’s skin is estimated or, alternatively, a grid of radio-opaque skin markers may be placed to help determine the entry point (Figure 5). The selected slice is surface marked, and the skin cleaned and draped (Figure 6). After administration of local anaesthesia (1% lignocaine), a small skin incision is made and the biopsy needle is directed into the lesion under intermittent CT fluoroscopy guidance. Some practitioners advocate infiltrating the paraspinal muscles and spinal periosteum as well with local anaesthetic, prior to insertion of the biopsy needle.
In biopsy of anteriorly-located lesions in the C3-C7 vertebrae, an anterolateral approach is usually adopted. As in the cervical discographic technique, the radiologists’ fingers are used to guard the carotid artery, together with the internal jugular vein and adjacent nerves, while the needle is directed towards the vertebral lesion. The needle should be inserted towards the vertebral body during the first pass, preferably from the patient’s right side, taking care to avoid puncturing the oesophagus and the trachea (Figure 7). Anteriorly-located lesions in C1 and the odontoid peg usually require a trans-oral approach, and in my opinion they should be preferably referred to the otolaryngological surgeon for biopsy.
For posteriorly-located cervical spine lesions (Figure 8) and lesions in the thoracic and lumbar spine, the transpedicular (Figures 2 and 9), transcostovertebral (Figure 10), or posterolateral paravertebral (Figures 3, 6 and 11) approaches are usually used. The accuracy rates of biopsies using the transpedicular and posterolateral approaches are similar [3]. A lateral approach that enables access to the lumbar vertebral body, intervertebral disc, and paravertebral mass has been described. The patient lies in a lateral decubitus position within the CT scanner. In this position, the abdominal viscera are displaced forwards, providing a clear view of the lateral aspect of the lumbar spine for needle insertion. An advantage of this approach is that the needle tip is away from the nerve roots. The lateral approach should not be used, however, if forward displacement of abdominal contents is insufficient to safely avoid puncture of the abdominal viscera by the biopsy needle [11]. A transforaminodiscal approach has been reported to be a safe alternative to the posterolateral approach [15]. The approach to be adopted depends on the exact site of the lesion and should be appropriately tailored for each patient.
The type of needle used depends on the nature of the lesion and the operator’s personal preference. A large variety of needles are available commercially [44]. They can be broadly classified into aspiration (e.g. spinal or Chiba), cutting or tru-cut (e.g. Quick-core or Temno), and trephine (e.g. Ostycut, Craig or Ackerman) needles. They range in size from 11G to 22G. In general, the needle should be long enough to reach the lesion and have the appropriate bore size to obtain an adequate amount of specimen. Aspiration needles have a fine gauge and are best used to aspirate fluid, soft tissue lesions, or disc contents for culture or cytology (Figure 12). Cutting needles may be used for obtaining solid specimens from bone or, more usually, soft tissue (Figure 13). Both aspiration and cutting needles may also be used in bony lesions with overlying cortical destruction (Figure 14). Trephine needles have a serrated cutting edge and are usually required to obtain bone specimens for histopathology (Figure 15). A coaxial technique may also be used and decreases the need to re-puncture the patient as several samples may be obtained via a single tract [15] (Figure 16). Whichever needle type is used, CT fluoroscopy should be intermittently done to ensure that the needle tip is in a safe position during its insertion and to confirm its placement within the lesion.
Ideally, the needle should be placed into different parts of the lesion to ensure representative sampling (Figure 17). In tumours, the necrotic or cystic areas should be avoided and the radiologist should try to identify these areas on CT or MR images prior to biopsy. Ideally, a cytotechnologist or cytopathologist should be present during the procedure to determine the adequacy of the tissue specimen. All material obtained should be sent for cytology, culture, and histopathological examination. CT-guided needle aspiration has been found to be accurate for identifying active bacterial disc infections, but is less reliable for fungal infections. Adding cytopathological analysis to microbiological analysis improves the sensitivity of infective lesions [12,19,45]. Blood clots may contain cells or organisms and should not be discarded [32]. Aspiration and core biopsy specimens have a complementary role [46].
The radiologist should be familiar with smear preparation on glass slides (Figure 18) and the various types of containers to be used for culture and histopathological specimens (Figure 19). All these specimens should be carefully labeled and dispatched promptly by a responsible person (Figure 20). The accuracy of the biopsy outcome depends on the type and location of the lesion, as well as the type of needle used. Core biopsy is more accurate than fine needle aspiration, while biopsies of malignant lesions have a higher accuracy rate compared with benign tumours and infection [7,13,18]. Compared with osteolytic malignant lesions, the diagnostic accuracy is decreased and the false-negative rate is higher for sclerotic lesions [17]. Thoracic level biopsies have been reported to have a lower diagnostic rate than lesions at other spinal levels [8].
After biopsy, the puncture site should be dressed and checked for possible complications. Prophylactic pain medication should be given to the patient. The length of the post- biopsy observation period depends on whether or not sedation was given. If the pleura is inadvertently punctured, further imaging to exclude a pneumothorax is indicated. The patient is sent home with instructions for pain medication, warned about possible complications, and told what to do if any occur.
COMPLICATIONS
The types and incidence of complications depends on the type of needle used and on the anatomical location of the lesion. Reported incidence rates are 0 to 10%, with serious complication rates being less than 1% [1-4,6-8,10-11,15-18,21,28]. Risks for imaging- guided biopsy are acknowledged to be less than those associated with surgical open biopsy under general anaesthesia. The most frequently reported complications are pulmonary, neurological, and infective [1,16,17,40-43,46-49] and include:
Bleeding requiring transfusion. Excessive local bleeding may be controlled by gelfoam insertion.
Needle breakage.
Infection.
Neurological injury, including paresis or paralysis. Cord compression may rarely occur after biopsy of hypervascular spinal lesions, e.g., metastatic renal cell carcinoma or haemangioma.
Pneumothorax. Rates of 4 to 11% after thoracic spine biopsy have been reported.
Tumour seeding along the needle track.
Infection spread along the needle track, with resultant formation of a draining sinus.
CONCLUSION
CT-guided percutaneous biopsy has a useful role in the diagnosis and the management of patients with spinal lesions. Most biopsies can be safely and rapidly performed under local anaesthesia. Meticulous technique, knowledge of the spinal anatomy and of indications and contraindications, and awareness of possible complications are essential for success.
REFERENCES
- 1.Murphy WA, Destouet JM, Gilula LA. Percutaneous skeletal biopsy 1981: a procedure for radiologists--results, review, and recommendations. Radiology. 1981;139(3):545–9. doi: 10.1148/radiology.139.3.7232719. [DOI] [PubMed] [Google Scholar]
- 2.Kattapuram SV, Rosenthal DI. Percutaneous biopsy of skeletal lesions. AJR Am J Roentgenol. 1991;157(5):935–42. doi: 10.2214/ajr.157.5.1927811. [DOI] [PubMed] [Google Scholar]
- 3.Pierot L, Boulin A. Percutaneous biopsy of the thoracic and lumbar spine: transpedicular approach under fluoroscopic guidance. AJNR Am J Neuroradiol. 1999;20(1):23–5. [PubMed] [Google Scholar]
- 4.Ashizawa R, Ohtsuka K, Kamimura M, et al. Percutaneous transpedicular biopsy of thoracic and lumbar vertebrae--method and diagnostic validity. Surg Neurol. 1999;52(6):545–51. doi: 10.1016/s0090-3019(99)00154-8. [DOI] [PubMed] [Google Scholar]
- 5.Renfrew DL, Whitten CG, Wiese JA, et al. CT-guided percutaneous transpedicular biopsy of the spine. Radiology. 1991;180(2):574–6. doi: 10.1148/radiology.180.2.2068332. [DOI] [PubMed] [Google Scholar]
- 6.Babu NV, Titus VT, Chittaranjan S, et al. Computed tomographically guided biopsy of the spine. Spine. 1994;19(21):2436–42. doi: 10.1097/00007632-199411000-00013. [DOI] [PubMed] [Google Scholar]
- 7.Dupuy DE, Rosenberg AE, Punyaratabandhu T, et al. Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol. 1998;171(3):759–62. doi: 10.2214/ajr.171.3.ajronline_171_3_001. [DOI] [PubMed] [Google Scholar]
- 8.Kornblum MB, Wesolowski DP, Fischgrund JS, et al. Computed tomography-guided biopsy of the spine. A review of 103 patients. Spine. 1998;23(1):81–5. doi: 10.1097/00007632-199801010-00018. [DOI] [PubMed] [Google Scholar]
- 9.Leffler SG, Chew FS. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic yield and accuracy. AJR Am J Roentgenol. 1999;172(5):1389–92. doi: 10.2214/ajr.172.5.10227522. [DOI] [PubMed] [Google Scholar]
- 10.Kang M, Gupta S, Khandelwal N, et al. CT-guided fine-needle aspiration biopsy of spinal lesions. Acta Radiol. 1999;40(5):474–8. doi: 10.3109/02841859909175570. [DOI] [PubMed] [Google Scholar]
- 11.Garces J, Hidalgo G. Lateral access for CT-guided percutaneous biopsy of the lumbar spine. AJR Am J Roentgenol. 2000;174(2):425–6. doi: 10.2214/ajr.174.2.1740425. [DOI] [PubMed] [Google Scholar]
- 12.Chew FS, Kline MJ. Diagnostic yield of CT-guided percutaneous aspiration procedures in suspected spontaneous infectious diskitis. Radiology. 2001;218(1):211–4. doi: 10.1148/radiology.218.1.r01ja06211. [DOI] [PubMed] [Google Scholar]
- 13.Hau A, Kim I, Kattapuram S, et al. Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal Radiol. 2002;31(6):349–53. doi: 10.1007/s00256-002-0474-3. [DOI] [PubMed] [Google Scholar]
- 14.Ozsarlak O, De Schepper AM, Wang X, et al. CT-guided percutaneous needle biopsy in spine lesions. JBR-BTR. 2003;86(5):294–6. [PubMed] [Google Scholar]
- 15.Sucu HK, Bezircioglu H, Cicek C, et al. Computerized tomography-guided percutaneous transforaminodiscal biopsy sampling of vertebral body lesions. J Neurosurg. 2003;99(1 Suppl):51–5. [PubMed] [Google Scholar]
- 16.Yaffe D, Greenberg G, Leitner J, et al. CT-guided percutaneous biopsy of thoracic and lumbar spine: A new coaxial technique. AJNR Am J Neuroradiol. 2003;24(10):2111–3. [PMC free article] [PubMed] [Google Scholar]
- 17.Lis E, Bilsky MH, Pisinski L, et al. Percutaneous CT-guided biopsy of osseous lesion of the spine in patients with known or suspected malignancy. AJNR Am J Neuroradiol. 2004;25(9):1583–8. [PMC free article] [PubMed] [Google Scholar]
- 18.Altuntas AO, Slavin J, Smith PJ, et al. Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours. ANZ J Surg. 2005;75(4):187–91. doi: 10.1111/j.1445-2197.2005.03332.x. [DOI] [PubMed] [Google Scholar]
- 19.Michel SC, Pfirrmann CW, Boos N, et al. CT-guided core biopsy of subchondral bone and intervertebral space in suspected spondylodiskitis. AJR Am J Roentgenol. 2006;186(4):977–80. doi: 10.2214/AJR.05.0109. [DOI] [PubMed] [Google Scholar]
- 20.Civardi G, Livraghi T, Colombo P, et al. Lytic bone lesions suspected for metastasis: ultrasonically guided fine-needle aspiration biopsy. J Clin Ultrasound. 1994;22(5):307–11. doi: 10.1002/jcu.1870220504. [DOI] [PubMed] [Google Scholar]
- 21.Gupta S, Takhtani D, Gulati M, et al. Sonographically guided fine-needle aspiration biopsy of lytic lesions of the spine: technique and indications. J Clin Ultrasound. 1999;27(3):123–9. doi: 10.1002/(sici)1097-0096(199903/04)27:3<123::aid-jcu4>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- 22.Saifuddin A, Mitchell R, Burnett SJ, et al. Ultrasound-guided needle biopsy of primary bone tumours. J Bone Joint Surg Br. 2000;82(1):50–4. doi: 10.1302/0301-620x.82b1.10141. [DOI] [PubMed] [Google Scholar]
- 23.Konermann W, Wuisman P, Ellermann A, et al. Ultrasonographically guided needle biopsy of benign and malignant soft tissue and bone tumors. J Ultrasound Med. 2000;19(7):465–71. doi: 10.7863/jum.2000.19.7.465. [DOI] [PubMed] [Google Scholar]
- 24.Gil-Sanchez S, Marco-Domenech SF, Irurzun-Lopez J, et al. Ultrasound-guided skeletal biopsies. Skeletal Radiol. 2001;30(11):615–9. doi: 10.1007/s002560100417. [DOI] [PubMed] [Google Scholar]
- 25.Lewin JS, Petersilge CA, Hatem SF, et al. Interactive MR imaging-guided biopsy and aspiration with a modified clinical C-arm system. AJR Am J Roentgenol. 1998;170(6):1593–601. doi: 10.2214/ajr.170.6.9609180. [DOI] [PubMed] [Google Scholar]
- 26.Koenig CW, Duda SH, Truebenbach J, et al. MR-guided biopsy of musculoskeletal lesions in a low-field system. J Magn Reson Imaging. 2001;13(5):761–8. doi: 10.1002/jmri.1106. [DOI] [PubMed] [Google Scholar]
- 27.Genant JW, Vandevenne JE, Bergman AG, et al. Interventional musculoskeletal procedures performed by using MR imaging guidance with a vertically open MR unit: assessment of techniques and applicability. Radiology. 2002;223(1):127–36. doi: 10.1148/radiol.2231010900. [DOI] [PubMed] [Google Scholar]
- 28.Wu L, Li C, Chen L, et al. Magnetic resonance imaging guided bone biopsies in the iPath-200 system. Chin Med J (Engl) 2003;116(6):937–40. [PubMed] [Google Scholar]
- 29.Schajowicz F, Derqui JC. Puncture biopsy in lesions of the locomotor system. Review of results in 4050 cases, including 941 vertebral punctures. Cancer. 1968;21(3):531–48. doi: 10.1002/1097-0142(196803)21:3<531::aid-cncr2820210325>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- 30.Murphy WA. Radiologically guided percutaneous musculoskeletal biopsy. Orthop Clin North Am. 1983;14(1):233–41. [PubMed] [Google Scholar]
- 31.Skrzynski MC, Biermann JS, Montag A, et al. Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 1996;78(5):644–9. doi: 10.2106/00004623-199605000-00002. [DOI] [PubMed] [Google Scholar]
- 32.Hewes RC, Vigorita VJ, Freiberger RH. Percutaneous bone biopsy: the importance of aspirated osseous blood. Radiology. 1983;148(1):69–72. doi: 10.1148/radiology.148.1.6856867. [DOI] [PubMed] [Google Scholar]
- 33.Tehranzadeh J, Freiberger RH, Ghelman B. Closed skeletal needle biopsy: review of 120 cases. AJR Am J Roentgenol. 1983;140(1):113–5. doi: 10.2214/ajr.140.1.113. [DOI] [PubMed] [Google Scholar]
- 34.Stoker DJ, Cobb JP, Pringle JA. Needle biopsy of musculoskeletal lesions. A review of 208 procedures. J Bone Joint Surg Br. 1991;73(3):498–500. doi: 10.1302/0301-620X.73B3.1670457. [DOI] [PubMed] [Google Scholar]
- 35.Kattapuram SV, Khurana JS, Rosenthal DI. Percutaneous needle biopsy of the spine. Spine. 1992;17(5):561–4. doi: 10.1097/00007632-199205000-00014. [DOI] [PubMed] [Google Scholar]
- 36.Ng CS, Salisbury JR, Darby AJ, et al. Radiologically guided bone biopsy: results of 502 biopsies. Cardiovasc Intervent Radiol. 1998;21(2):122–8. doi: 10.1007/s002709900227. [DOI] [PubMed] [Google Scholar]
- 37.Hodge JC. Percutaneous biopsy of the musculoskeletal system: a review of 77 cases. Can Assoc Radiol J. 1999;50(2):121–5. [PubMed] [Google Scholar]
- 38.Logan PM, Connell DG, O'Connell JX, et al. Image-guided percutaneous biopsy of musculoskeletal tumors: an algorithm for selection of specific biopsy techniques. AJR Am J Roentgenol. 1996;166(1):137–41. doi: 10.2214/ajr.166.1.8571862. [DOI] [PubMed] [Google Scholar]
- 39.Binkert CA, Verdun FR, Zanetti M, et al. CT arthrography of the glenohumeral joint: CT fluoroscopy versus conventional CT and fluoroscopy--comparison of image-guidance techniques. Radiology. 2003;229(1):153–8. doi: 10.1148/radiol.2291020314. [DOI] [PubMed] [Google Scholar]
- 40.Peh WC. Imaging-guided bone biopsy. Ann Acad Med Singapore. 2003;32(4):557–61. [PubMed] [Google Scholar]
- 41.Hodge JC. Bone biopsies. In: Hodge JC, editor. Musculoskeletal Imaging: Diagnostic and Therapeutic Procedures. Basel: Karger Landes; 1997. pp. 203–22. [Google Scholar]
- 42.Ghelman B. Biopsies of the musculoskeletal system. Radiol Clin North Am. 1998;36(3):567–80. doi: 10.1016/s0033-8389(05)70045-2. [DOI] [PubMed] [Google Scholar]
- 43.Hallet RL. Musculoskeletal tumors, percutaneous needle biopsy. EMedicine J. 2002 [Google Scholar]
- 44.Roberts CC, Morrison WB, Leslie KO, et al. Assessment of bone biopsy needles for sample size, specimen quality and ease of use. Skeletal Radiol. 2005;34(6):329–35. doi: 10.1007/s00256-004-0859-6. [DOI] [PubMed] [Google Scholar]
- 45.White LM, Schweitzer ME, Deely DM, et al. Study of osteomyelitis: utility of combined histologic and microbiologic evaluation of percutaneous biopsy samples. Radiology. 1995;197(3):840–2. doi: 10.1148/radiology.197.3.7480765. [DOI] [PubMed] [Google Scholar]
- 46.Schweitzer ME, Gannon FH, Deely DM, et al. Percutaneous skeletal aspiration and core biopsy: complementary techniques. AJR Am J Roentgenol. 1996;166(2):415–8. doi: 10.2214/ajr.166.2.8553958. [DOI] [PubMed] [Google Scholar]
- 47.Arca MJ, Biermann JS, Johnson TM, et al. Biopsy techniques for skin, soft-tissue, and bone neoplasms. Surg Oncol Clin N Am. 1995;4(1):157–74. [PubMed] [Google Scholar]
- 48.Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996;78(5):656–63. doi: 10.2106/00004623-199605000-00004. [DOI] [PubMed] [Google Scholar]
- 49.Olscamp A, Rollins J, Tao SS, et al. Complications of CT-guided biopsy of the spine and sacrum. Orthopedics. 1997;20(12):1149–52. doi: 10.3928/0147-7447-19971201-09. [DOI] [PubMed] [Google Scholar]